CVS vs. SOLV: CVS Health vs. Solventum Stock Comparison

Company Profile

CVS Health (CVS) and Solventum (SOLV) both fall under the Health Care Equipment & Services industry group, but CVS is classified in Health Care Providers & Services while SOLV is classified in Health Care Equipment & Supplies.

CVS Health (CVS) carries decades of public-market history since February 21, 1973, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the CVS side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both CVS Health (CVS) at 14.36% and Solventum (SOLV) at 3.19% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Both CVS Health (CVS) at 2.64% and Solventum (SOLV) at 1.91% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both CVS Health (CVS) at 2.72% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

CVS Health (CVS) at 7.85% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Solventum (SOLV) at 221.74% delivers above-range EPS growth, while CVS Health (CVS) at -62.02% falls into the bottom quartile — a wide split in earnings momentum.

Growth Metrics

Financial Strength

Both CVS Health (CVS) at 0.85 and Solventum (SOLV) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both CVS Health (CVS) at 0.93 and Solventum (SOLV) at 1.10 lean more heavily on debt funding than most peers, landing in the higher-leverage quartile of their industries.

Financial Strength Metrics

Dividends

Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a yield of 3.27%, ranking against industry peers normally.

Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a payout of 30.89%, ranking against industry peers normally.

Dividend Metrics

Valuation

CVS Health (CVS) at 9.74 sits in the cheaper P/E ratio quartile, while Solventum (SOLV) at 101.55 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while Solventum (SOLV) at 1.88 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.

CVS Health (CVS) at 1.33 sits in the lower P/B ratio quartile against book while Solventum (SOLV) at 3.20 is valued near its industry’s middle — CVS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics